Uncovering Translational Biomarkers for Disease Monitoring & Mechanistic Insights of Drugs
Time: 1:00 pm
day: Day One Track B, PM
Details:
• Key translational biomarkers for indications such as LN and MS for enhanced disease monitoring and therapeutic activity
• Leveraging translational biomarkers to provide early insights in clinical trials
• How does the application of cell therapies alter the biomarker approach in these diseases? And where do they overlap to provide historical benchmarking?
